Clinical Trials Directory

Trials / Completed

CompletedNCT03967366

Melatonin and Coronary Artery Calcification

Association Between Plasma Melatonin and Coronary Artery Calcification

Status
Completed
Phase
Study type
Observational
Enrollment
574 (actual)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The investigators planned to research the association between plasma melatonin and coronary artery calcification in a Chinese population.

Detailed description

Coronary artery calcification (CAC) is prevalent in coronary artery disease (CHD), and the extent of CAC predicts cardiovascular risk. The causes of CAC include dysregulated matrix metabolism, epitaxial mineral deposition, inflammation, oxidative stress, and apoptosis. Melatonin is the main indoleamine produced by the pineal gland; it is known recently to have anti-inflammatory, anti-cancer and antioxidant activities. Several studies have shown that melatonin protects against inflammation and apoptosis in vascular calcification. Melatonin also inhibits oxidative stress-induced apoptosis and calcification in endplate chondrocytes. However, no study has evaluated whether melatonin is associated with CAC in patients with coronary atherosclerosis. The investigators planned to research the association between plasma melatonin and coronary artery calcification.

Conditions

Timeline

Start date
2017-05-01
Primary completion
2019-04-30
Completion
2019-04-30
First posted
2019-05-30
Last updated
2019-05-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03967366. Inclusion in this directory is not an endorsement.